BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 7, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Pozen Licenses MT 300 Rights To Xcel In Deal Worth At Least $10M

Sep. 5, 2003
By Aaron Lorenzo

CAT Avoids Patent Fight, Enters Deal With Enzon And Micromet

Sep. 4, 2003
By Aaron Lorenzo

CAT Avoids Patent Fight, Enters Deal With Enzon And Micromet

Sep. 4, 2003
By Aaron Lorenzo

AVI Terminates Planned Buyout Of eXegenics As Offer Expires

Sep. 3, 2003
By Aaron Lorenzo
Another merger agreement has fallen apart for eXegenics Inc. For the second time in the past year, the Dallas-based company saw its plans dissolve about two months after initially reporting a decision to combine with another firm. The latest suitor to walk away, AVI BioPharma Inc., said an insufficient number of eXegenics shareholders agreed to the tender offer. (BioWorld Today)
Read More

AVI Terminates Planned Buyout Of eXegenics As Offer Expires

Sep. 3, 2003
By Aaron Lorenzo
Another merger agreement has fallen apart for eXegenics Inc. For the second time in the past year, the Dallas-based company saw its plans dissolve about two months after initially reporting a decision to combine with another firm. The latest suitor to walk away, AVI BioPharma Inc., said an insufficient number of eXegenics shareholders agreed to the tender offer. (BioWorld Today)
Read More

Explosions Hit Chiron In Wake Of Recent Animal Rights Protests

Sep. 2, 2003
By Aaron Lorenzo
Chiron Corp. was bombed last week in what may have been the latest and most violent offense in a string of harassment incidents brought by animal rights protesters. (BioWorld Today)
Read More

Explosions Hit Chiron In Wake Of Recent Animal Rights Protests

Sep. 2, 2003
By Aaron Lorenzo
Chiron Corp. was bombed last week in what may have been the latest and most violent offense in a string of harassment incidents brought by animal rights protesters. (BioWorld Today)
Read More

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Aug. 29, 2003
By Aaron Lorenzo

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Aug. 29, 2003
By Aaron Lorenzo

Nymox Raises $12M Privately To Provide Three Years' Cash

Aug. 28, 2003
By Aaron Lorenzo
Previous 1 2 … 174 175 176 177 178 179 180 181 182 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 6, 2026.
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • University of Southern California reports new MAPT aggregation inhibitors

    BioWorld Science
    The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing